ATE520664T1 - TYROSINE KINASE INHIBITORS - Google Patents
TYROSINE KINASE INHIBITORSInfo
- Publication number
- ATE520664T1 ATE520664T1 AT06785319T AT06785319T ATE520664T1 AT E520664 T1 ATE520664 T1 AT E520664T1 AT 06785319 T AT06785319 T AT 06785319T AT 06785319 T AT06785319 T AT 06785319T AT E520664 T1 ATE520664 T1 AT E520664T1
- Authority
- AT
- Austria
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- inhibitors
- tyrosine
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69322905P | 2005-06-23 | 2005-06-23 | |
| US72906105P | 2005-10-21 | 2005-10-21 | |
| US78947306P | 2006-04-05 | 2006-04-05 | |
| PCT/US2006/024256 WO2007002258A2 (en) | 2005-06-23 | 2006-06-22 | Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE520664T1 true ATE520664T1 (en) | 2011-09-15 |
Family
ID=37595817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06785319T ATE520664T1 (en) | 2005-06-23 | 2006-06-22 | TYROSINE KINASE INHIBITORS |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1896422B1 (en) |
| KR (1) | KR20080018907A (en) |
| AR (1) | AR057377A1 (en) |
| AT (1) | ATE520664T1 (en) |
| BR (1) | BRPI0612518A2 (en) |
| CR (1) | CR9579A (en) |
| CY (1) | CY1112038T1 (en) |
| DO (1) | DOP2006000143A (en) |
| EC (1) | ECSP078017A (en) |
| IL (1) | IL187895A0 (en) |
| MA (1) | MA29643B1 (en) |
| MX (1) | MX2007016533A (en) |
| NI (1) | NI200700318A (en) |
| NO (1) | NO20080417L (en) |
| NZ (1) | NZ563711A (en) |
| PE (1) | PE20070167A1 (en) |
| PL (1) | PL1896422T3 (en) |
| PT (1) | PT1896422E (en) |
| SI (1) | SI1896422T1 (en) |
| TW (1) | TW200738638A (en) |
| WO (1) | WO2007002258A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200813021A (en) | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| US7893081B2 (en) * | 2007-12-20 | 2011-02-22 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| WO2011039527A1 (en) | 2009-09-30 | 2011-04-07 | Merck Sharp & Dohme Ltd | Formulations for c-met kinase inhibitors |
| EP2482821A4 (en) | 2009-09-30 | 2013-03-06 | Merck Sharp & Dohme | Crystalline hydrochloride salts of c-met kinase inhibitors |
| US20130315895A1 (en) | 2010-07-01 | 2013-11-28 | Takeda Pharmaceutical Company Limited | COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| ES2764299T3 (en) | 2014-12-09 | 2020-06-02 | Inst Nat Sante Rech Med | Human monoclonal antibodies against AXL |
| WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| US20220401436A1 (en) | 2019-11-08 | 2022-12-22 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2286275T3 (en) * | 2001-09-19 | 2007-12-01 | Pharmacia Corporation | PIRAZOLO COMPOUNDS REPLACED FOR THE TREATMENT OF INFLAMMATION. |
| WO2003084931A1 (en) * | 2002-04-02 | 2003-10-16 | Merck & Co., Inc. | 5h-benzo[4,5]cyclohepta[1,2-b]pyridine nmda/nr2b antagonists |
-
2006
- 2006-06-14 TW TW095121232A patent/TW200738638A/en unknown
- 2006-06-16 AR ARP060102571A patent/AR057377A1/en not_active Application Discontinuation
- 2006-06-21 PE PE2006000702A patent/PE20070167A1/en not_active Application Discontinuation
- 2006-06-22 NZ NZ563711A patent/NZ563711A/en not_active IP Right Cessation
- 2006-06-22 BR BRPI0612518-2A patent/BRPI0612518A2/en not_active IP Right Cessation
- 2006-06-22 KR KR1020077030202A patent/KR20080018907A/en not_active Application Discontinuation
- 2006-06-22 PL PL06785319T patent/PL1896422T3/en unknown
- 2006-06-22 EP EP06785319A patent/EP1896422B1/en active Active
- 2006-06-22 PT PT06785319T patent/PT1896422E/en unknown
- 2006-06-22 SI SI200631136T patent/SI1896422T1/en unknown
- 2006-06-22 AT AT06785319T patent/ATE520664T1/en active
- 2006-06-22 MX MX2007016533A patent/MX2007016533A/en unknown
- 2006-06-22 WO PCT/US2006/024256 patent/WO2007002258A2/en active Application Filing
- 2006-06-23 DO DO2006000143A patent/DOP2006000143A/en unknown
-
2007
- 2007-12-04 IL IL187895A patent/IL187895A0/en unknown
- 2007-12-04 NI NI200700318A patent/NI200700318A/en unknown
- 2007-12-07 CR CR9579A patent/CR9579A/en not_active Application Discontinuation
- 2007-12-14 EC EC2007008017A patent/ECSP078017A/en unknown
-
2008
- 2008-01-22 NO NO20080417A patent/NO20080417L/en not_active Application Discontinuation
- 2008-01-23 MA MA30591A patent/MA29643B1/en unknown
-
2011
- 2011-11-16 CY CY20111101099T patent/CY1112038T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007002258A2 (en) | 2007-01-04 |
| EP1896422B1 (en) | 2011-08-17 |
| KR20080018907A (en) | 2008-02-28 |
| PT1896422E (en) | 2011-11-08 |
| AR057377A1 (en) | 2007-11-28 |
| PL1896422T3 (en) | 2012-01-31 |
| ECSP078017A (en) | 2008-01-23 |
| TW200738638A (en) | 2007-10-16 |
| EP1896422A2 (en) | 2008-03-12 |
| DOP2006000143A (en) | 2007-02-28 |
| CR9579A (en) | 2008-03-06 |
| MX2007016533A (en) | 2008-03-06 |
| PE20070167A1 (en) | 2007-04-16 |
| NZ563711A (en) | 2010-12-24 |
| BRPI0612518A2 (en) | 2010-11-23 |
| NO20080417L (en) | 2008-03-18 |
| CY1112038T1 (en) | 2015-11-04 |
| IL187895A0 (en) | 2008-03-20 |
| MA29643B1 (en) | 2008-07-01 |
| NI200700318A (en) | 2008-05-23 |
| WO2007002258A3 (en) | 2007-06-07 |
| SI1896422T1 (en) | 2011-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017012I1 (en) | BRUTON TYROSINE KINASE INHIBITORS | |
| ATE493403T1 (en) | KINASE INHIBITORS | |
| DK1979356T3 (en) | CARBONYLAMINOPYRROLOPYRAZOLES, POWERFUL KINASE INHIBITORS | |
| NO20082517L (en) | Aminopyrimidines useful as kinase inhibitors | |
| ATE520671T1 (en) | PYRIMIDINE-UREA DERIVATIVES AS KINASE INHIBITORS | |
| DK1926722T3 (en) | Substituted benzimidazoles as kinase inhibitors | |
| BRPI0810086A2 (en) | bruton tyrosine kinase inhibitors | |
| DK1704145T3 (en) | Selective kinase inhibitors | |
| IL186845A0 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
| DE602007008837D1 (en) | AS PROTEIN KINASE INHIBITORS USEFUL DYHYDRODIAZEPINE | |
| DK2099447T3 (en) | IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS | |
| ATE433449T1 (en) | KINASE INHIBITORS | |
| EP2040546A4 (en) | Tyrosine kinase inhibitors | |
| ATE530545T1 (en) | PYRAZOLYLAMINOPYRIDINE DERIVATIVES SUITABLE AS KINASE INHIBITORS | |
| ATE518860T1 (en) | PYRROLOÄ2,3-BÜPYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | |
| BRPI0716781A2 (en) | Kinase Inhibitors | |
| IL177007A0 (en) | 2-(3-substituted-aryl) amino-4-thiazoles as tyrosine kinase inhibitors | |
| IL190078A0 (en) | Kinase inhibitors | |
| IL196337A0 (en) | Tyrosine kinase inhibitors | |
| ATE520664T1 (en) | TYROSINE KINASE INHIBITORS | |
| DK2035385T3 (en) | Act inhibitors (protein kinase B) | |
| ATE472532T1 (en) | OXINDOLS AS KINASE INHIBITORS | |
| EP1951252A4 (en) | Tyrosine kinase inhibitors | |
| ATE521603T1 (en) | QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS | |
| DK2170891T3 (en) | Pyrazolopyrimidinon kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1896422 Country of ref document: EP |